Regulations.gov document
Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability…
Notice · FDA-2017-D-6580 · posted Mar 21, 2018
Key facts
| Document ID | FDA-2017-D-6580-3476 |
|---|---|
| Title | Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2017-D-6580 |
| Posted | Mar 21, 2018 |
| Federal Register citation | 83 FR 12398 |
| FR document number | 2018-05659 |
| Comment period opens | Mar 21, 2018 |
| Comments due | May 22, 2018 |
| Effective date | Mar 21, 2018 |
At a glance
- 1–9 Pages
- No Open for comment
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: